DDI Study With Multiple-dose LX4211 and Single Dose Rosuvastatin
Clinical trial NCT02300363 · COMPLETED
Trial details
- NCT number
- NCT02300363
- Sponsor
- Lexicon Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2014-11-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.